Dr. Michael Anthony Dempsey, MD

  • Rockville, MD
  • Endocrinologist
NPI1730197229PAC ID0840466348
Part D claims, 2024
1,919
Publications
3
Clinical trials
40
Industry payments
$51,776
Affiliated sites
1
Practice address
9901 Medical Center Dr, Rockville, MD 20850
Practice phone
Call (301) 279-6155
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Shady Grove Adventist Hospital

Rockville, Maryland

See all 3 affiliations

Find Dr. Dempsey's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Michael Anthony Dempsey is an endocrinologist in Rockville, Maryland

Dr. Dempsey practices at Shady Grove Adventist Hospital in Rockville, Maryland.

Dr. Dempsey's NPI, 1730197229, was assigned on August 3, 2006. Dr. Dempsey graduated from Harvard Medical School in 1983. Dr. Dempsey holds Maryland license D34292.

NPI and contact details
Medicare PAC ID
0840466348
NPI enumeration date
August 3, 2006
NPI status
Active
Practice phone
(301) 279-6155
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Medical school graduation
1983

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data

Dr. Michael Anthony Dempsey practices at Shady Grove Adventist Hospital in Rockville, Maryland

Dr. Dempsey's primary practice is Shady Grove Adventist Hospital, at 9901 Medical Center Dr, Rockville, MD 20850 in Montgomery County. The practice phone is (301) 279-6155.

  • Shady Grove Adventist Hospital
    9901 Medical Center Dr, Rockville, MD 20850 · Montgomery CountyPhone(301) 279-6155

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Michael Anthony Dempsey is affiliated with 2 sites of care and 1 medical group

Dr. Dempsey's primary practice is Shady Grove Adventist Hospital in Rockville, Maryland. Dmand AI also links Dr. Dempsey to 1 group practice or clinic and 1 medical group, each named with a free account.

See all 3 affiliations for Dr. Dempsey

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Michael Anthony Dempsey's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dempsey practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Shady Grove Adventist HospitalAvailable with a free account
+1 more site and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Dempsey practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Michael Anthony Dempsey is one of 248 endocrinologists in Maryland

Endocrinology, diabetes and metabolism is Dr. Dempsey's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Dempsey is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Dempsey's licenses on file in 2 states: Maryland and District of Columbia.

Specialties and state licenses

  • Endocrinology, diabetes and metabolism, MarylandPrimaryLicense D34292 · 1986 to 2026 · taxonomy 207RE0101X
  • District of Columbia license1985 to 1986

Clinical focus

Dmand AI lists diabetic emergency among the conditions Dr. Dempsey treats.

Endocrinologists near Dr. Dempsey

Counts of endocrinologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Michael Anthony Dempsey's patients have a median age of 65

Across all payers, Dmand AI patient panel data puts Dr. Dempsey's median patient age at 65, with 60% women.

Dr. Dempsey's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 65

Patient panel by sex, all payers

  • Women60%
  • Men39%

Source: Dmand AI Patient Panel Data

Dr. Michael Anthony Dempsey wrote 1,919 Medicare Part D claims in 2024

In 2024, Dr. Dempsey wrote 1,919 Medicare Part D claims for 188 patients. 46% of them were for generic drugs. CMS names the drug for 1,576 of them, across 37 drugs with 11 or more claims each, at $805,317 in total drug cost. In 2023, CMS named 1,209 claims across 36 drugs.

Part D claims, 20241,919
Drugs named by CMS37
Total drug cost$805,317
Part D patients188

Dr. Dempsey's Part D claims by kind of drug, 2024

  • Generic885 claims46%
  • Brand-name919 claims48%
  • Other115 claims6%

Dr. Dempsey's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Dempsey's Part D claims, 2024

  • Antibiotics1%12 of 1,919 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,2092024: 1,57630%

Drugs named by CMS: 37 in 2024, 36 in 2023.

See all prescribing by Dr. Dempsey

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

For MedTech and pharma teams

Find endocrinologists like Dr. Dempsey by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Michael Anthony Dempsey has 3 publications on record

Dmand AI links 3 papers to Dr. Dempsey, published from 2018 to 2025. The most frequent topics are Diabetes Mellitus, Type 2, Hypoglycemic Agents and Drug Combinations. Dr. Dempsey's most frequent co-author is Andrew S. Rhinehart, FACP, MD.

Papers3
Years published2018 to 2025

Topics Dr. Dempsey writes about most

  • Diabetes Mellitus, Type 2
  • Hypoglycemic Agents
  • Drug Combinations
  • Glycated Hemoglobin
  • Insulin Aspart
  • Insulin Glargine
  • Insulin, Long-Acting
  • Liraglutide

Dr. Dempsey's most frequent co-authors

Recent publications by Dr. Dempsey

See all 3 publications and co-authors

See who Dr. Dempsey researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Dempsey works with, so you can find a warm path to the right endocrinologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Michael Anthony Dempsey has worked on 40 clinical trials

Dmand AI links Dr. Dempsey to 40 clinical trials, 18 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Diabetes Mellitus, Type 2, Diabetes Mellitus and Diabetes Mellitus, Type 1. Sanofi sponsors the most, 11. Open Payments lists research payments to Dr. Dempsey that name 8 trials.

Clinical trials with Dr. Dempsey by phase

  1. NonePhase 1: no trials
  2. 1Phase 2: 1 trial
  3. 18Phase 3: 18 trials
  4. NonePhase 4: no trials

Conditions in Dr. Dempsey's trials

  • Diabetes Mellitus, Type 2
  • Diabetes Mellitus
  • Diabetes Mellitus, Type 1
  • Autoimmune Diseases
  • Acute Coronary Syndrome

Investigators on the most trials with Dr. Dempsey

Recent clinical trials with Dr. Dempsey

See all 40 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Michael Anthony Dempsey received $51,776 in industry payments from 2016 to 2022

CMS Open Payments shows 68 general payments to Dr. Dempsey from 8 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 81% of the total. Sanofi and Genzyme US Companies paid the most, $33,965. It also lists 15 research payments totaling $81,581 from 2018 to 2024, naming 8 clinical trials.

General payments to Dr. Dempsey by program year, 2016 to 2022

General payments to Dr. Dempsey by kind, 2016 to 2022

$51.8Kin total
  • Consulting fees$41,95081%
  • Travel and lodging$6,36912%
  • Food and beverage$3,0586%
  • Speaker and faculty fees$3901%
  • Education$80%

Companies that paid Dr. Dempsey the most, 2016 to 2022

Share is of all general payments to this clinician.

See all payments to Dr. Dempsey

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Michael Anthony Dempsey has 7 awards and honors on record

Dmand AI lists 7 awards for Dr. Dempsey, most recently Compassionate Doctor Award in 2021. Dr. Dempsey serves on AACE Public Impact Committee.

Awards and honors for Dr. Dempsey

  1. 2021
    • Compassionate Doctor Award
    • Top Doctors
    • Top Doctors Endocrinology and Metabolism
  2. 2018
    • Volunteer of the Year
  3. 1991
    • ACP Fellow
  4. Undated
    • Checkbook Top Doc
See all 7 awards

Dr. Dempsey's committees and leadership roles

AACE Public Impact CommitteeMember
2018 to present
AACE Underserved Population CommitteeCommittee member
2016 to 2018
AACE Clinical Research CommitteeCommittee member
2012 to 2015
Community Outreach Committee Montgomery County Medical SocietyChair
2011 to 2012
Healthy MontgomerySteering Committee
2011 to 2012

Source: Dmand AI Professional Profile Data

Dr. Michael Anthony Dempsey graduated from Harvard Medical School

Dr. Dempsey graduated from Harvard Medical School in 1983. Dr. Dempsey is a member of ADA and ENDO.

  1. Medical schoolHarvard Medical School
  2. Board certified in endocrinology, diabetes and metabolismAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Michael Anthony Dempsey's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Michael Anthony Dempsey

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Michael Anthony Dempsey's NPI number?

Dr. Michael Anthony Dempsey's NPI number is 1730197229. It was assigned on August 3, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Michael Anthony Dempsey?

Dr. Michael Anthony Dempsey is an endocrinologist in Rockville, Maryland. The primary specialty in the NPI Registry is Endocrinology, Diabetes & Metabolism Physician (taxonomy code 207RE0101X).

Where does Dr. Michael Anthony Dempsey practice?

Dr. Dempsey practices at 9901 Medical Center Dr, Rockville, MD 20850. Dr. Dempsey's primary practice is Shady Grove Adventist Hospital in Rockville, Maryland. Dmand AI also links Dr. Dempsey to 1 group practice or clinic and 1 medical group.

What is Dr. Michael Anthony Dempsey's office phone number?

The practice phone on file for Dr. Dempsey is (301) 279-6155.

What is Dr. Michael Anthony Dempsey's medical license number?

Dr. Dempsey holds Maryland license D34292, one of the licenses on file in 2 states.

Which states has Dr. Michael Anthony Dempsey been licensed in?

Dmand AI has state licenses on file for Dr. Dempsey in Maryland (1986 to 2026) and District of Columbia (1985 to 1986).

Is Dr. Michael Anthony Dempsey board certified?

Yes. Dr. Dempsey is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine.

Where did Dr. Michael Anthony Dempsey go to medical school?

Dr. Dempsey graduated from Harvard Medical School in 1983.

What drugs does Dr. Michael Anthony Dempsey prescribe most?

In 2024 Medicare Part D data, Dr. Dempsey's most prescribed drugs by claims were Synthroid, Ozempic and Jardiance.

Has Dr. Michael Anthony Dempsey received payments from drug or device companies?

CMS Open Payments shows $51,776 in general payments to Dr. Dempsey from 8 companies from 2016 to 2022. The largest total came from Sanofi and Genzyme US Companies.

Show 3 more questionsShow fewer questions

How long has Dr. Michael Anthony Dempsey been practicing?

Dr. Dempsey graduated from medical school in 1983, 43 years ago.

Does Dr. Michael Anthony Dempsey do research?

Dmand AI links 3 publications to Dr. Dempsey, published from 2018 to 2025. Dr. Dempsey has worked on 40 clinical trials.

Who does Dr. Michael Anthony Dempsey publish with?

Dr. Dempsey's most frequent co-authors are Andrew S. Rhinehart, FACP, MD (1 shared paper).

Selling to endocrinology, diabetes and metabolism practices?

See endocrinologists in Maryland by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)